NCT02691637View on ClinicalTrials.gov

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

CompletedOBSERVATIONAL

Enrollment

1,450

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2022

Study Completion Date

December 31, 2022

Conditions

Helicobacter Pylori InfectionAtrophic GastritisIntestinal Metaplasia

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

collaborator

National Clinical Research Coordination Center, Seoul, Korea

OTHER_GOV

lead

Seoul National University Bundang Hospital

OTHER

NCT02691637 - Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients | Biotech Hunter | Biotech Hunter